WYNN
41
4
TDC
67
2
PHM
48
2
PNC
67
4
JNPR
56
-3
WMT
68
-2
IR
57
2
EMR
59
2
RF
72
5
MO
60
-3
HPQ
62
2
CME
67
8
PPL
77
-5
DAL
72
7
MTB
69
2
XEL
65
-4
WMB
58
-5
M
39
3
RRC
72
2
HBI
59
-8
WYNN
41
4
TDC
67
2
PHM
48
2
PNC
67
4
JNPR
56
-3
WMT
68
-2
IR
57
2
EMR
59
2
RF
72
5
MO
60
-3
HPQ
62
2
CME
67
8
PPL
77
-5
DAL
72
7
MTB
69
2
XEL
65
-4
WMB
58
-5
M
39
3
RRC
72
2
HBI
59
-8
Financhill
Back

Jazz Pharmaceuticals PLC Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
21

JAZZ
Jazz Pharmaceuticals PLC

Last Price:
$97.80
Seasonality Move:
46.06%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Jazz Pharmaceuticals PLC Stock Forecast

  • Over the next 52 weeks, Jazz Pharmaceuticals PLC has on average historically risen by 81.6% based on the past 17 years of stock performance.
  • Jazz Pharmaceuticals PLC has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
  • Is Jazz Pharmaceuticals PLC Stock Undervalued?
    The current Jazz Pharmaceuticals PLC [JAZZ] share price is $98.41. The Score for JAZZ is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • JAZZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Jazz Pharmaceuticals PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Jazz Pharmaceuticals PLC has on average historically risen by 81.6% based on the past 17 years of stock performance.

Jazz Pharmaceuticals PLC Stock Rating

Sell
21
Jazz Pharmaceuticals PLC (JAZZ) is a Sell

Is Jazz Pharmaceuticals PLC overpriced?

  • Jazz Pharmaceuticals PLC has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%

Jazz Pharmaceuticals PLC Stock Price History

Is JAZZ stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JAZZ is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Ireland
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
jazzpharmaceuticals.com

52-Week Data

52-Week High:
148.06
52-Week Low:
95.49

Prediction Charts

Market Cap:
6.1B
Price in USD:
98.41
Volume:
2.2M
Beta:
1.23

Technical Analysis

SMA50:
122.15
SMA100:
123.54
SMA200:
118.50
52-Wk Change:
-11.1%

Stock Predictions

  • Is Jazz Pharmaceuticals PLC stock public?
    Yes, Jazz Pharmaceuticals PLC is a publicly traded company.
  • What is the Jazz Pharmaceuticals PLC stock quote today?
    The Jazz Pharmaceuticals PLC stock price is 98.41 USD today.
  • How to buy Jazz Pharmaceuticals PLC stock online?
    You can buy Jazz Pharmaceuticals PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 101.92 103.38 103.86 101.22
Apr-23 105.00 104.19 106.77 103.76
Apr-24 104.37 108.98 109.23 103.51
Apr-25 108.52 110.80 111.17 107.66
Apr-28 111.22 112.89 114.47 111.22
Apr-29 112.34 116.41 117.09 111.20
Apr-30 116.05 116.96 117.57 113.92
May-1 116.35 117.18 117.79 113.53
May-2 118.82 120.05 120.67 118.75
May-5 120.05 118.19 120.57 118.14
May-6 117.50 111.17 118.00 110.81
May-7 105.51 101.44 109.08 100.85
May-8 101.58 98.41 104.06 97.50
May-9 98.61 97.78 99.98 97.56

Jazz Pharmaceuticals PLC Earnings

Jazz Pharmaceuticals PLC Earnings Report: Per Share Jazz Pharmaceuticals PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Jazz Pharmaceuticals PLC Forecast Revenue Growth

Jazz Pharmaceuticals PLC Stock Analysis: Historical quarterly revenues per share for Jazz Pharmaceuticals PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.22 per share, a decrease this year of $15.21 per share, and an increase next year of $16.54 per share.

* Jazz Pharmaceuticals PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.